Type III collagen is the second most abundant collagen in tissues and is found most commonly in tissues exhibiting elastic properties such as skin, lungs, intestinal walls and walls of blood vessels. It is a homotrimer comprised of three alpha-1 chains and resembles other fibrillar collagens in structure and function. It is synthesized as procollagen, similary to collagen I, but the N-terminal propeptide remains attached in the mature fibrillar type III form.
Mutations of type III collagen causes Ehlers-Danlos syndrome, EDS IV, which affect arteries, internal organs, joints and skin, and may cause sudden death when the large arteries rupture.
Symbols/Related Terms:
Description: Purified Bovine Collagen Type III (Atelocollagen) from bovine placenta
Form: Lyophilized, salt free, 10 mg/ vial
Sterility: Passed sterility test for bacteria and fungi
Source: Bovine placenta
Purity: Bovine Collagen Type III (Atelocollagen) > 90% / Bovine Collagen Type I (Atelocollagen) < 10%
Purification: Partial pepsin digestion in acidic conditions and differential salt precipitation.
Reconstitution: Dissolve in 10-50 mM acetic acid. Suspension should be shaken or stirred for several hours or overnight between 2-8°C. Material is dissolved when it appears homogeneous, with no schlieren pattern (light refraction due to differing protein concentrations in the suspension). Recommended concentration 1-5 mg/ml.
Storage: Bovine Collagen Type III (Atelocollagen) dissolved in acetic acid is stable at 4°C for 1 month. Lyophilized collagen long term storage (2 years) at -20°C or lower.
Application: Coating material for cell culture studies or 3D gel formation.
Bovine Collagen Type III (Atelocollagen) Insert (PDF)
Note: inserts are for review only. Please refer to the insert shipped with your product to ensure the most up-to-date revision is being used.
Dissolve in 10-50 mM acetic acid. Suspension should be shaken or stirred for several hours or overnight between 2-8°C. Material is dissolved when it appears homogeneous, with no schlieren pattern (light refraction due to differing protein concentrations in the suspension). Recommended concentration 1-5 mg/ml.
MD Biosciences成立于1991年,总部位于瑞士,在美国、加拿大和英国设有办事处,是一家领先的研发和临床阶段的制药和生物技术的公司,提供尖端的研究服务,创新的生物产品和先进的诊断能力。我们在炎症和神经学领域拥有超过25年的无与伦比的科学专业知识和专有方法历史,这些使我们一直处于精确医学运动的前沿。
其主要产品包括:
抗体 (软骨蛋白聚糖、胶原蛋白、激素、神经药物)、细胞培养相关试剂 (胶原蛋白、细胞增殖检测、支原体PCR检测)、疾病诱导试剂 (关节炎诱导抗体混合、弗氏佐剂、胶原蛋白II等)、ELISA试剂盒(糖蛋白、细胞因子、激素等)、同型对照、天然蛋白以及重组蛋白(胶原类等)。